Showing results (141-150 of 192) with videos related to

Sort By:
Pageof 20
JCO Oncology Practice|February 21, 2024
Receipt of Guideline-Concordant Care Is Associated With Improved Survival in Patients With Osteosarcoma in California: A Population-Based AnalysisRenata Abrahão, Theresa H M Keegan, Frances B Maguire, et al.
BMJ Open|February 27, 2021
Willingness of patients with sarcoma to participate in cancer surveillance research: a cross-sectional patient surveyPatricia Schneider, Victoria Giglio, Dana Ghanem, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 24, 2012
Atypical intradermal smooth muscle neoplasms (formerly cutaneous leiomyosarcomas): case series, immunohistochemical profile and review of the literatureBrian J Hall, Allie H Grossmann, Nicholas P Webber, et al.
Pediatric Blood & Cancer|April 23, 2014
HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology studySarah Gorlick, Donald A Barkauskas, Mark Krailo, et al.
European Journal of Cancer (Oxford, England : 1990)|October 7, 2019
Phase II trial of the glycoprotein non-metastatic B-targeted antibody-drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the Children's Oncology GroupLisa M Kopp, Suman Malempati, Mark Krailo, et al.
Journal of the National Cancer Institute|November 9, 2017
Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the FutureKarlyne M Reilly, AeRang Kim, Jaishri Blakely, et al.
Oncotarget|February 3, 2017
C/EBPβ-1 promotes transformation and chemoresistance in Ewing sarcoma cellsJamie D Gardiner, Lisa M Abegglen, Xiaomeng Huang, et al.
Pediatric Blood & Cancer|May 6, 2008
Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group Bone Tumor CommitteeJames S Meyer, Helen R Nadel, Neyssa Marina, et al.
Cancer Genetics|August 8, 2012
Molecular inversion probe analysis detects novel copy number alterations in Ewing sarcomaMona S Jahromi, Angelica R Putnam, Colleen Druzgal, et al.
Pediatric Blood & Cancer|December 3, 2014
Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology GroupDaniel M Lerman, Michael J Monument, Elizabeth McIlvaine, et al.
Pageof 20